Publicaciones (23) Publicaciones en las que ha participado algún/a investigador/a

2012

  1. A novel formulation of solubilised amphotericin B designed for ophthalmic use

    International Journal of Pharmaceutics, Vol. 437, Núm. 1-2, pp. 80-82

  2. Continuous twin screw granulation: Influence of process variables on granule and tablet quality

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 82, Núm. 1, pp. 205-211

  3. Controlled release of rasagiline mesylate promotes neuroprotection in a rotenone-induced advanced model of Parkinson's disease

    International Journal of Pharmaceutics, Vol. 438, Núm. 1-2, pp. 266-278

  4. Differences in lercanidipine systemic exposure when administered according to labelling: In fasting state and 15 minutes before food intake

    European Journal of Clinical Pharmacology, Vol. 68, Núm. 7, pp. 1043-1047

  5. Effect of allicin on promastigotes and intracellular amastigotes of Leishmania donovani and L. infantum.

    Experimental parasitology, Vol. 132, Núm. 4, pp. 475-482

  6. Effects of corneal thickness on the intraocular penetration of travoprost 0.004%

    Eye (Basingstoke), Vol. 26, Núm. 7, pp. 972-975

  7. Enantiomerical pharmacokinetic prevalence of (+) albendazole sulphoxide in Trichinella spiralis muscle larvae

    Parasitology Research, Vol. 110, Núm. 2, pp. 993-999

  8. Enhanced removal of phenol with saline solution over alcohol: An in vitro study

    Dermatologic Surgery, Vol. 38, Núm. 8, pp. 1296-1301

  9. Exploring flubendazole formulations for use in sheep. Pharmacokinetic evaluation of a cyclodextrin-based solution

    BMC Veterinary Research, Vol. 8

  10. Interfacial interaction between transmembrane ocular mucins and adhesive polymers and dendrimers analyzed by surface plasmon resonance

    Pharmaceutical Research, Vol. 29, Núm. 8, pp. 2329-2340

  11. Investigation on the need of multiple dose bioequivalence studies for prolonged-release generic products

    International Journal of Pharmaceutics, Vol. 423, Núm. 2, pp. 321-325

  12. Matrix tablets: The effect of hydroxypropyl methylcellulose/anhydrous dibasic calcium phosphate ratio on the release rate of a water-soluble drug through the gastrointestinal tract I. in vitro tests

    AAPS PharmSciTech, Vol. 13, Núm. 4, pp. 1073-1083

  13. Mechanical and drug delivery properties of a chitosan-tartaric acid hydrogel suitable for biomedical applications

    Journal of Applied Polymer Science, Vol. 123, Núm. 2, pp. 842-849

  14. Mucoadhesive tablets for controlled release of acyclovir

    Chemical and Pharmaceutical Bulletin, Vol. 60, Núm. 10, pp. 1249-1257

  15. Pectina: Usos Farmacéuticos y Aplicaciones Terapéuticas

    Anales de la Real Academia Nacional de Farmacia, Núm. 1, pp. 82-97

  16. Pectina: Usos farmaceúticos y aplicaciones terapéuticas

    Anales de la Real Academia Nacional de Farmacia, Vol. 78, Núm. 1, pp. 82-97

  17. Pharmacist's role in the studies of the veterinary-medicines-residues depletion

    Pharmaceuticals Policy and Law, Vol. 14, Núm. 2-4, pp. 223-228

  18. Poly-ε-caprolactone microspheres as a drug delivery system for cannabinoid administration: Development, characterization and in vitro evaluation of their antitumoral efficacy

    Journal of Controlled Release, Vol. 161, Núm. 3, pp. 927-932

  19. Preservation of biological activity of glial cell line-derived neurotrophic factor (GDNF) after microencapsulation and sterilization by gamma irradiation

    International Journal of Pharmaceutics, Vol. 436, Núm. 1-2, pp. 545-554

  20. Recent patents and developments in glaucoma biomarkers

    Recent Patents on Endocrine, Metabolic and Immune Drug Discovery, Vol. 6, Núm. 3, pp. 224-234